Godrej Agrovet sales rise 10% in Q1 FY27; appoints Ravishankar A. as CFO

scanx
Reviewed by
Riya DScanX News Team
Key Highlights

Godrej Agrovet Limited achieved 10% sales growth in Q1 FY27, reaching ₹2,852 crore, despite a decline in net profit to ₹128.31 crore. Strong performance in Animal Nutrition and Oil Palm offset challenges in Crop Care due to monsoon delays. The Board approved the appointment of Ravishankar A. as CFO, effective October 1, 2026.

powered bylight_fuzz_icon
47471639

*this image is generated using AI for illustrative purposes only.

Godrej Agrovet Limited reported a 10% year-on-year increase in consolidated sales to ₹2,852 crore for the first quarter ended June 30, 2026, driven by strong performance in Animal Nutrition and Oil Palm segments. Despite the top-line growth, net profit declined to ₹128.31 crore from ₹148.83 crore in Q1 FY26, reflecting margin pressures from elevated input costs and delayed monsoons impacting Crop Care volumes. The Board of Directors, meeting on August 5, 2026, approved the unaudited financial results and announced the appointment of Ravishankar A. as Chief Financial Officer, effective October 1, 2026, following the early superannuation of S. Varadaraj.

The earnings call held on August 6, 2026, provided deeper insights into segment performance and strategic outlooks. Managing Director Sunil Kataria highlighted that Animal Nutrition revenue grew 12.6% to ₹1,302.09 crore, supported by a 15% rise in cattle feed volumes and improved realizations. The Oil Palm business saw segment revenue surge 28.9%, aided by higher crude palm oil (CPO) realizations and improved oil extraction efficiency (OER), which rose to 18.8% from 18.4% in the previous year. Conversely, Crop Care revenue fell 16.2% due to a 40% deficit in June rainfall, delaying kharif sowing and reducing demand for cotton herbicides.

Segment-Wise Performance

Segment: Revenue (₹ crore): YoY Change: Key Drivers:
Animal Nutrition: 1,302.09 +12.6% Cattle feed volume growth (+15%), premiumization
Vegetable Oil: 619.24 +24.1% Higher CPO/PKO realizations, improved OER
Crop Care: 349.02 -13.3% Delayed monsoon, lower cotton herbicide volumes
Dairy: 464.63 +11.5% Value-added product growth, volume recovery
Poultry & Processed Food: 188.17 +0.7% Branded portfolio expansion, live bird degrowth

Astec LifeSciences continued its operational recovery, achieving EBITDA breakeven compared to an EBITDA loss of ₹11 crore in Q1 FY26. The company also noted that its Bangladesh joint venture, ACI Godrej Agrovet, returned to double-digit growth in volumes and profit before tax.

Strategic Outlook and Leadership Transition

S. Varadaraj requested early superannuation from his role as CFO and Head – Finance & Legal, effective September 30, 2026. The Board appointed Ravishankar A., formerly Vice President – Finance at Hindustan Unilever, as CFO-designate from September 21, 2026, with full appointment commencing October 1, 2026. This transition marks a significant shift in the company’s finance leadership.

Looking ahead, management maintained its guidance for mid-teens profit before tax growth for FY27, though it emphasized that final outcomes depend on Crop Care recovery in the second half. New product launches, including Ashitaka (maize herbicide) and Takai (paddy insecticide), are expected to contribute 18–20% of Q1 sales in their first season, diversifying the Crop Care portfolio beyond cotton herbicides. In the Oil Palm segment, the company plans to expand area coverage from 80,000 to 150,000 hectares over the long range, targeting high single-digit to early double-digit fresh fruit bunch (FFB) volume growth annually.

What the Numbers Show

The divergence between robust revenue growth (10%) and declining net profit (13.8%) highlights persistent margin compression across key segments. While Animal Nutrition and Oil Palm delivered strong top-line momentum, profitability was eroded by input cost inflation—particularly in milk procurement for Dairy and packaging costs linked to geopolitical tensions. The strategic pivot in Foods towards branded B2C products (growing at 28% volume) versus planned degrowth in live bird trading signals a structural shift towards higher-margin consumer offerings, albeit with short-term investment pressures.

Historical Stock Returns for Godrej Agrovet

1 Day5 Days1 Month6 Months1 Year5 Years
+0.42%+2.56%+21.54%+12.21%-8.74%0.0%

How will the new CFO, Ravishankar A., leverage his FMCG background to address the current margin compression and optimize the shift towards higher-margin B2C branded products?

Given the 40% rainfall deficit impacting Crop Care, what specific hedging strategies or inventory management tactics will Godrej Agrovet employ to mitigate further revenue volatility in Q2 FY27?

What is the projected capital expenditure timeline for expanding the Oil Palm area from 80,000 to 150,000 hectares, and how might this impact free cash flow in the near term?

Godrej Agrovet publishes investor call audio recording for August 6, 2026

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights

Godrej Agrovet Limited has published the audio recording of its investor conference call held on August 6, 2026, at 3:30 p.m. IST. The recording is accessible via the company's website, ensuring transparency for all shareholders. The filing was submitted to BSE and NSE, signed by Vivek Raizada, Head – Legal & Company Secretary.

powered bylight_fuzz_icon
47587769

*this image is generated using AI for illustrative purposes only.

Godrej Agrovet Limited has released the audio recording of its conference call with investors and analysts, providing stakeholders access to management commentary from the session held on Thursday, August 6, 2026. The call, which commenced at 3:30 p.m. (IST), allows market participants to review discussions regarding the company's operational updates and strategic outlook directly from executive leadership.

The disclosure was made to comply with regulatory requirements for transparency and accessibility of material information. By hosting the recording on its corporate website, Godrej Agrovet Limited ensures that all shareholders, including those who could not attend live, have equal opportunity to hear the management's perspective on recent developments.

Accessing the Recording

The audio file is hosted on the company's official domain, ensuring security and authenticity. Investors can download or stream the content using the link provided in the exchange filing.

Detail Information
Event Conference Call with Investors & Analysts
Date August 6, 2026
Time 3:30 p.m. (IST)
Platform Company Website

The filing was submitted to both the BSE Limited (Scrip Code: 540743) and the National Stock Exchange of India Limited (Symbol: GODREJAGRO). The communication was signed by Vivek Raizada, Head – Legal & Company Secretary & Compliance Officer, affirming the accuracy of the disclosure.

Regulatory Compliance

This release aligns with standard practices for listed entities in India, where post-event recordings of earnings calls or strategic briefings are mandated to be made available for a specified period. The availability of the recording supports informed decision-making by retail and institutional investors alike.

What This Means for Investors

While the filing itself does not contain new financial data, the availability of the recording is critical for analysts seeking detailed insights beyond summarized press releases. It enables a deeper understanding of management's tone, emphasis areas, and responses to specific analyst queries during the session. Stakeholders are advised to review the recording for any forward-looking statements or clarifications on recent operational metrics.

Historical Stock Returns for Godrej Agrovet

1 Day5 Days1 Month6 Months1 Year5 Years
+0.42%+2.56%+21.54%+12.21%-8.74%0.0%

What specific operational metrics or strategic shifts did management emphasize during the August 6 call that could impact Godrej Agrovet's near-term revenue growth?

How might the management's commentary on recent developments influence institutional investor sentiment and trading volume in the coming weeks?

Are there any forward-looking statements regarding capital expenditure or expansion plans mentioned in the recording that could alter the company's long-term valuation?

More News on Godrej Agrovet

1 Year Returns:-8.74%